Hermetica Superfood Encyclopedia
The Short Answer
Pokeweed contains pokeweed antiviral protein (PAP), a ribosome-inactivating protein (RIP) that depurinates the sarcin/ricin loop of 28S rRNA to halt viral and cellular protein synthesis, alongside phenolic compounds (seeds: up to 155.83 mg GAE/g dry weight) and triterpene saponins. All demonstrated benefits—including antiproliferative activity in breast, colon, and cervical cancer cell lines and anti-inflammatory effects in carrageenan-induced rat paw edema models—remain confined to preclinical in vitro and animal studies, with no human clinical trial data available.
CategoryHerb
GroupEuropean
Evidence LevelPreliminary
Primary Keywordpokeweed benefits and dangers
Pokeweed — botanical close-up
Health Benefits
**Antiviral Activity via PAP**
Pokeweed antiviral protein (PAP) functions as an RNA N-glycosidase that depurinates a critical adenine residue in the sarcin/ricin loop of 28S rRNA, irreversibly inactivating ribosomes and thereby blocking viral protein synthesis in infected cells.
**Anti-inflammatory Effects**
Triterpene saponin extracts containing phytolaccagenin have demonstrated statistically significant reduction of carrageenan-induced rat paw edema in animal models, suggesting cyclooxygenase-pathway modulation, though this has not been validated in humans.
**Antioxidant Capacity**
Phenolic and flavonoid fractions exhibit free radical scavenging activity via DPPH assay, with seed extracts yielding the highest total phenolic content at 155.83 mg GAE/g dry weight, indicating meaningful electron-donating capacity at the molecular level.
**Antiproliferative and Cytotoxic Properties**
Ethanolic and aqueous extracts induce apoptosis in breast, colon, and cervical cancer cell lines in vitro, with ribosomal inactivation by PAP proposed as a central mechanism, though no therapeutic index for human use has been established.
**Antifungal Activity**
Peptide fractions isolated from pokeweed demonstrate fungistatic activity against select fungal pathogens, with the mechanism attributed to membrane disruption by cationic antifungal peptides, documented qualitatively in laboratory assays.
**Acetylcholinesterase Inhibition**
Seed-derived 1,4-benzodioxane derivatives and other fractions show acetylcholinesterase inhibitory activity in vitro, which theoretically elevates synaptic acetylcholine levels, though this has not been evaluated in any neurological disease model in vivo.
**Neuritogenic Potential**
Seed derivatives have been reported to promote neurite outgrowth in preliminary cell-based assays, suggesting possible neuroprotective or nerve-regenerative applications that remain entirely speculative without further mechanistic or animal study confirmation.
Origin & History
Phytolacca americana is native to eastern North America, ranging from the Gulf Coast to southern Canada, and has naturalized across parts of Europe, North Africa, and East Asia. It thrives in disturbed soils, roadsides, forest margins, and cleared lands, preferring moist, nutrient-rich environments at low to mid elevations. Though not commercially cultivated for medicinal use, it grows vigorously as a perennial, reaching up to 3 meters in height, and was historically harvested from wild stands by Appalachian and Native American communities.
“Native American tribes including the Cherokee, Iroquois, and Algonquin peoples used various parts of Phytolacca americana for medicinal purposes, including root poultices for rheumatism, skin infections, and tumors, and berry-based preparations for syphilis and other systemic infections, with careful attention to the plant's known toxicity. In Appalachian folk medicine, pokeweed occupied a prominent role as a spring tonic, with the practice of 'poke sallet'—young boiled leaves eaten as a seasonal green—forming part of the regional culinary and medicinal heritage celebrated in the 1969 song 'Polk Salad Annie.' The plant was controversially included in the Hoxsey herbal tonic, a widely marketed mid-20th-century alternative cancer remedy that combined multiple botanical agents and was ultimately deemed ineffective and potentially dangerous by the U.S. Food and Drug Administration. European herbalists became familiar with pokeweed following its naturalization across the continent, incorporating it into early phytomedicinal texts, though mainstream European botanical medicine has generally discouraged its internal use due to well-documented toxicological concerns.”Traditional Medicine
Scientific Research
The totality of published evidence for pokeweed's medicinal properties consists exclusively of in vitro cell culture experiments, animal pharmacology studies, and phytochemical characterization assays—no human clinical trials of any design have been conducted or reported. Antiproliferative and apoptotic effects have been documented against breast, colon, and cervical cancer cell lines using solvent-derived extracts, with planned but not yet completed mouse xenograft models for cytotoxicity assessment. Anti-inflammatory activity has been quantified in carrageenan-induced rat paw edema models using saponin fractions, and antioxidant potency has been measured via DPPH radical scavenging, yielding IC50 values ranging from 341.99 ± 15.3 µg/ml (callus extract) to 11,256.51 µg/ml (root extract), indicating highly variable and generally moderate potency. The evidence base is therefore rated as preliminary and insufficient to support any therapeutic or nutritional dosing recommendation, and the compound's toxicity profile further complicates translation of preclinical findings to human use.
Preparation & Dosage
Traditional preparation
**Traditional Appalachian preparation (poke sallet)**
Young spring leaves (first 15–20 cm of growth) boiled in multiple changes of water to leach toxins before consumption as a cooked green—this method reduces but does not eliminate toxic lectins and saponins and is not recommended by modern standards.
**Root decoctions (historical)**
Small amounts of dried root were used in folk medicine as a cathartic and anti-rheumatic; no safe dose has ever been established, and root preparations are considered the most toxic part of the plant.
**Berries (historical)**
Berries were used externally as a dye and in some folk remedies; internal consumption of raw berries causes severe gastrointestinal toxicity and is contraindicated.
**Standardized extracts (research only)**
Laboratory studies use solvent-extracted fractions (ethanol, methanol, or aqueous) at concentrations of 20–100 µl per assay well; these are analytical preparations not intended for human administration.
**PAP-immunotoxin conjugates (investigational)**
PAP has been explored as a component of experimental immunotoxin constructs in cancer research, conjugated to antibodies targeting tumor antigens; these are investigational biologics and have not received regulatory approval.
**No established supplemental dose exists**
Given toxicity and the absence of clinical trials, no safe, effective, or standardized supplemental dose can be recommended for any form or preparation of pokeweed.
Nutritional Profile
Pokeweed is not utilized as a significant dietary source of macronutrients or micronutrients under safe conditions. Young cooked leaves contain modest amounts of vitamin C, vitamin A precursors (beta-carotene), calcium, and iron, but these data are not well-standardized and the preparation required to reduce toxicity diminishes nutrient content. The primary phytochemical constituents of note include total phenolics (seeds: 155.83 mg GAE/g; leaves: 14.03–26.03 mg GAE/g dry weight), total flavonoids (leaves highest; callus: 11.73 ± 0.5 mg QE/g), triterpene saponins including phytolaccagenin, betacyanin pigments (responsible for the deep red-purple berry color), histamine, GABA, and ribosome-inactivating proteins (PAP). Bioavailability of phenolic compounds from pokeweed has not been studied in humans, and the concurrent presence of toxic lectins and saponins substantially confounds any nutritional evaluation of the plant as a food source.
How It Works
Mechanism of Action
The primary and best-characterized mechanism of pokeweed is ribosome inactivation by PAP, a type I ribosome-inactivating protein that cleaves the N-glycosidic bond of a specific adenine residue (A4324 in rat 28S rRNA) within the sarcin/ricin loop, permanently disrupting the elongation factor binding site and arresting translocation during protein synthesis, which effectively kills any cell or virus dependent on that ribosome. Triterpene saponins, particularly phytolaccagenin, are proposed to reduce prostaglandin-mediated inflammatory signaling, likely through inhibition of cyclooxygenase enzymes or reduction of pro-inflammatory cytokine release, as suggested by the carrageenan paw edema animal model. Phenolic and flavonoid compounds contribute antioxidant activity by donating hydrogen atoms or electrons to free radicals, chelating transition metals, and potentially modulating Nrf2-mediated antioxidant response element gene expression. Additional bioactive constituents including histamine, GABA, and acetylcholinesterase inhibitors suggest peripheral vascular and cholinergic nervous system modulation, though these mechanisms remain poorly characterized and without confirmed receptor-level data in humans.
Clinical Evidence
No clinical trials in human subjects have been identified for pokeweed or any isolated fraction thereof, including PAP, phytolaccagenin, or pokeweed phenolic extracts, for any health indication. All mechanistic and efficacy data originate from in vitro systems and rodent models, precluding any determination of effect size, therapeutic dose, or comparative efficacy relative to established treatments. The most advanced stage of investigation involves planned mouse xenograft studies for cytotoxic applications, which have not yet yielded published outcomes. Confidence in any clinical benefit is therefore extremely low, and the ingredient cannot be recommended for therapeutic use based on current evidence.
Safety & Interactions
Pokeweed is considered a toxic plant in all parts—root, berry, seed, and mature leaves—due to the presence of phytolaccatoxin, phytolaccigenin saponins, pokeweed mitogens (lectins), and PAP, a ribosome-inactivating protein; ingestion of raw plant material can cause severe nausea, vomiting, profuse diarrhea, hypotension, tachycardia, respiratory depression, and in documented cases, death, with children and elderly individuals at particular risk. No safe therapeutic dose or standardized extract has been established for any medicinal application, and the FDA does not recognize pokeweed as GRAS (Generally Recognized As Safe) for dietary supplement use. There are no well-characterized pharmacokinetic drug interaction studies, but the theoretical risk of additive toxicity exists with anticoagulants (due to mitogen-induced lymphocyte activation), immunosuppressants (due to potent mitogenic activity on B and T lymphocytes), and cholinergic medications (due to acetylcholinesterase inhibition). Pokeweed is absolutely contraindicated in pregnancy—pokeweed mitogens are teratogenic in animal models—in lactation, in children, and in individuals with gastrointestinal, hepatic, or renal compromise; it should not be used medicinally or as a dietary supplement under any circumstances without specialized medical supervision.
Synergy Stack
Hermetica Formulation Heuristic
Also Known As
Phytolacca americanaPokePokeberryInkberryPigeonberryPoke salletAmerican pokeweedCoakumCancer jalap
Frequently Asked Questions
Is pokeweed safe to eat or use as a supplement?
Pokeweed is not safe to eat raw or to use as a dietary supplement; all parts of the plant—particularly the root, seeds, and mature berries—contain toxic lectins, saponins (phytolaccatoxin), and the ribosome-inactivating protein PAP, which can cause severe vomiting, diarrhea, cardiovascular depression, and death. The traditional Appalachian practice of 'poke sallet' involved boiling young leaves in multiple changes of water to partially reduce toxins, but this method is unreliable and not endorsed by modern toxicologists or regulatory agencies. No safe supplemental dose has ever been established, and pokeweed has not received GRAS status from the FDA.
What is pokeweed antiviral protein (PAP) and how does it work?
Pokeweed antiviral protein (PAP) is a type I ribosome-inactivating protein (RIP) found in Phytolacca americana that functions as an RNA N-glycosidase, cleaving the N-glycosidic bond of a specific adenine residue within the sarcin/ricin loop of 28S ribosomal RNA. This depurination permanently disrupts the ribosome's ability to bind elongation factors, halting protein synthesis at the translocation step—a mechanism that kills both infected cells and viruses dependent on host ribosomes for replication. PAP has been investigated as a component of experimental immunotoxin constructs in cancer research, conjugated to antibodies targeting tumor cells, but no PAP-based therapy has received regulatory approval for human use.
What did Native Americans and Appalachian communities use pokeweed for?
Native American tribes including the Cherokee and Iroquois used pokeweed root poultices topically for rheumatism, skin infections, and tumor-like growths, while berry preparations were employed for systemic conditions such as syphilis, with traditional practitioners well aware of the plant's potent toxicity and dosing it accordingly. In Appalachian folk medicine, young spring pokeweed leaves were boiled repeatedly and eaten as 'poke sallet,' a seasonal tonic green believed to purify the blood after winter. Pokeweed was also controversially included in the Hoxsey tonic, a 20th-century herbal cancer remedy later discredited by the FDA, reflecting the plant's longstanding but unvalidated reputation as an antitumor agent.
Does pokeweed have anti-cancer properties supported by research?
Laboratory studies have demonstrated that pokeweed extracts and isolated PAP induce apoptosis and inhibit proliferation in breast, colon, and cervical cancer cell lines in vitro, and mouse xenograft models to further evaluate cytotoxicity have been planned but not yet published. However, all evidence is preclinical—no human clinical trials have been conducted—and the same cytotoxic mechanisms that might target cancer cells also damage normal tissue, making therapeutic application extremely challenging without targeted delivery systems such as antibody-drug conjugates. The evidence is therefore classified as preliminary, and pokeweed cannot be recommended as a cancer treatment or preventive agent.
What are the symptoms of pokeweed poisoning?
Pokeweed poisoning typically presents in a characteristic sequence: initial burning and irritation of the mouth and throat, followed within 2–6 hours by severe nausea, projectile vomiting, profuse watery or bloody diarrhea, and abdominal cramping, which result from saponins and lectins disrupting gastrointestinal epithelial cells. Systemic absorption can cause hypotension, tachycardia, bradycardia, respiratory depression, seizures, and—in severe cases, particularly in children who ingest berries—death from cardiovascular or respiratory failure. Treatment is supportive and symptomatic, involving fluid replacement and monitoring; cases of suspected pokeweed ingestion should be directed immediately to poison control or emergency medical services.
What forms of pokeweed are available as supplements, and how do they differ?
Pokeweed supplements are typically available as standardized extracts, tinctures, dried herb powders, and isolated PAP (pokeweed antiviral protein) preparations. Standardized extracts provide consistent levels of active compounds like saponins and PAP, while tinctures offer faster absorption through liquid delivery. PAP-isolated supplements target specific antiviral mechanisms, whereas whole-plant extracts may provide broader phytochemical profiles with potentially synergistic effects.
Does pokeweed interact with antiviral medications or immunosuppressants?
Pokeweed's PAP mechanism of blocking viral protein synthesis could theoretically potentiate some antiviral drugs, though clinical interaction data is limited. Because pokeweed stimulates immune function, it may counteract immunosuppressive medications used after transplants or for autoimmune conditions, making concurrent use inadvisable without medical supervision. Anyone taking prescription antivirals or immunosuppressants should consult a healthcare provider before using pokeweed supplements.
How strong is the clinical evidence for pokeweed's effectiveness in humans compared to laboratory studies?
Most evidence for pokeweed's antiviral and anti-inflammatory effects comes from in vitro and animal studies, particularly regarding PAP's mechanism against viral ribosomes. Human clinical trials specifically testing pokeweed supplements remain limited, with most historical use documented through traditional and ethnobotanical sources rather than controlled trials. While laboratory research demonstrates promising molecular activity, translating these findings to reliable human dosing and efficacy requires additional well-designed clinical studies.
Explore the Full Encyclopedia
7,400+ ingredients researched, verified, and formulated for optimal synergy.
Browse IngredientsThese statements have not been evaluated by the Food and Drug Administration. This content is for informational purposes only and is not intended to diagnose, treat, cure, or prevent any disease.
hermetica-encyclopedia-canary-zzqv9k4w pokeweed-phytolacca-americana curated by Hermetica Superfoods at ingredients.hermeticasuperfoods.com and licensed CC BY-NC-SA 4.0 (non-commercial share-alike, attribution required)
